Focus on Chinese medicine health industry.
Consun Pharmaceutical Group is a modern pharmaceutical enterprise mainly engaged in the R&D,
production and marketing of modern Chinese medicines and medical imaging contrast mediums.
It's founded in 1997 and got listed on the main board of The Stock Exchange of Hong Kong on December 19th ,2013.
Its medicines are mainly applied in diagnostic imaging and treating diseases of kidney, skin, bone, hepatobiliary digestive systems etc.
We have 146 varieties including 63 varieties of traditional Chinese medicines and 83 varieties of western medicines. 35 varieties enter the National Essential Medicine List. 73 varieties enter the National Health Insurance List. 15 varieties are listed in the National Herbal Protection Variety, such as Uremic Clearance Granules, Shiduqing Capsule, Zhenggushui, Jigucao Capsule and so on.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 东鹏大道71号, 71,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.chinaconsun.com/
- Keywords
- Guangzhou Consun Pharmaceutical Co..
- HQ
- 广州市, 广东省
Consun Pharmaceutical Group Questions
Consun Pharmaceutical Group's website is http://www.chinaconsun.com/
Consun Pharmaceutical Group's LinkedIn profile is https://cn.linkedin.com/company/chinaconsun
Consun Pharmaceutical Group has
7 employees.
View email and phone details for 7
employees at Consun Pharmaceutical Group.
Consun Pharmaceutical Group's industry is
Pharmaceutical Manufacturing
Consun Pharmaceutical Group's top competitors are
Hermitage Capital,
Carbmee,
Airwallex,
Guangzhou Consun Pharmaceutical Co., Ltd.,
1x,
Nt Pharma,
Tjr Succession,
Blp,
Capital 49,
Ascletis Pharma Inc..
Consun Pharmaceutical Group's categories are Pharmaceutical Manufacturing
Consun Pharmaceutical Group's founding year is 1997
